Navigation Links
Details Of Heart Failure Discovered

Canadian researchers have found out how the heart fails, and hope that this may make it easier to treat //the condition.

The researchers have worked to find out how the metabolic pathways differentiate in healthy versus failing hearts. They had found that in the early stages of heart failure, the heart uses too much fatty acid and not enough carbohydrate; and then, later, it doesn't use enough fat.

Gary Lopaschuk, a pharmacologist and professor in the University of Alberta Department of Pediatrics, and his colleagues say they've discovered that the type of "fuel" the heart uses can contribute to the severity of heart failures.

Normally, a heart derives energy from a balance of fatty acids and carbohydrates, specifically glucose.

"Many forms of heart diseases have many pharmacological therapeutic approaches to treat it," Lopaschuk said. "But heart failure is a difficult one.

"If you're diagnosed with heart failure, your five-year prognosis isn't good; there's a high likelihood of mortality," he said. "So there's a major push to find new approaches to treat heart failure."

He said heart failure does not necessarily mean the heart completely fails, but rather is a condition in which the heart fails to provide itself with enough blood under certain conditions.

The research will be published in the July edition of Physiological Reviews.

(IANS)


Medindia on heart failure- further information

Heart failure: This is the condition in which the heart loses the ability to pump blood normally. This condition is also known as congestive heart failure. This may be chronic condition or may develop suddenly. In this condition the organs are unable to receive their share of oxygen and nutrients and thus may not function to their fullest capacities. Most function of the body can be affected by the condition of heart failure.


'"/>




Page: 1 2

Related medicine news :

1. Details of Cosmetic Surgery in a Special Website.
2. New Zealand Requests Details from Britain about ‘Black Sheep
3. One in Three Heart Attack Patients Have No Chest Pains
4. Epileptic Seizures Can Be Due to Heart Problem
5. Bypass Heart Surgery Performed Without General Anesthesia
6. New CPR Guidelines issued by Heart Association
7. White Cells Count Can Predict Heart Attack Death Risk
8. Vitamins-The answer to Heart Disease?
9. Fight Heart disease and Pain with Meditation
10. Heart disease in the newborn is related to maternal malnutrition
11. New drug to treat Heart Attack and damaged tissue
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Details Heart Failure Discovered

(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...hysical wounds, a new study says//. Phillip Maruch...s at Chicago in a study of laboratory mice, found ...nt, delayed the closing of wounds by more than 45 ...rtal eurekalert.org. A range of cell and genetic ...
...ven when people are not aware of their learning ex... 2005 issue of Nature. Researchers from University...he San Diego Veterans Affairs Health System had un...e animals humans could learn through habits formed...
...elp to prevent a certain type of hereditary// deaf...ssor in otolaryngology at the University of Iowa, ...tically deafened mouse interfering RNA (Ribonuclei...ene from being expressed that would otherwise caus...
...me men to help them improve their sexual performan...ics. Apparently the same patches can be used in wo...increase their sexual desire and activity. In a st... month the authors have looked at 447 women diagno...
Other Medicine News:Health News:Habit Memory May Enhance Learning In People 2Health News:Testosterone Patches Found To Increase Sexual Desire In Menopausal Women 2
(Date:10/14/2008)...TON, Oct. 14 /- Paratek Pharmaceutica...t, amadacycline, formerly PTK 0796, a,first-in-cla...te Breaker,poster presentation at the 48th Intersc...therapy (ICAAC). ICAAC will be held in Washington,...nformation on the poster session at ICAAC:, Su...
(Date:10/13/2008)...nalysis of SPIRIT II and SPIRIT III Data Confirms ...of Experiencing Death, a Heart Attack or a ...ars, WASHINGTON, Oct. 13 /...,s SPIRIT II and SPIRIT III randomized clinical,tr... Eluting Coronary Stent,System continues to delive...
(Date:10/13/2008)...nsion of Genomic DNA from Multiple Cancer Populati... Studies, ANN ARBOR, Mich., Oct. 13 /PRNewswire/ ...ment with SAIC-Frederick to amplify DNA samples fo...ics was selected to amplify and standardize total ...om cancer patients. The Rubicon,GenomePlex(TM) Who...
(Date:10/10/2008)...HINGTON and MENLO PARK, Calif., Oct. 10 /PRNewswir... announced that it plans to present,long-term foll...trials next,week at the Cardiovascular Research Fo...rdiovascular Therapeutics (TCT) meeting in Washing...e studies designed to investigate,the safety and e...
Breaking Medicine Technology:Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra Levitra and Cialis Type Tablets 2336 1TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra Levitra and Cialis Type Tablets 2336 2Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 1Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 2Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference 5849 1Safety of Synthetic Turf Validated by NJ Test Results 21231 1Safety of Synthetic Turf Validated by NJ Test Results 21231 2Safety of Synthetic Turf Validated by NJ Test Results 21231 3
...nox Maintained Stability,Significantly Longer than...ile Comparable with Placebo , MARIETTA, Ga. and CO...cals, Inc., Wyeth Pharmaceuticals, a division of W...al study results on,bifeprunox, an investigational...ophrenia, today at the 2007 annual meeting of,the ...
...Approval of SEROQUEL XR--, WILMINGTON, Del., May 2...y announced that two analyses from a large-scale,s...(TM) (quetiapine,fumarate) Extended-Release Tablet...zophrenia in adult patients, were presented today,...Association,(APA). These analyses from the clinica...
Other Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
The Blackstone Spinal Fixation System is a sophisticated fixation system that provides an innovative solution to spinal stabilization. It combines technical advances in strength and stability with a
...is a versatile, low profile, titanium implant comp...trumentation needed for implantation. Reduction in...g concept. Monosegmental and multisegmental applic... with over 8,000 implantations. Tested in accordan...
...em is a comprehensive and versatile hook, rod and ...nd degenerative cases. Conceived with a complete u...LA/VSP Spine System employs segmental fixation and...bilize the spine. In deformity cases, the ISOLA/VS...
Transcranial and peripheral vascular doppler system.
Medicine Products: